Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Mitowel (Mitomycin Injection 10 mg)
Mitowel is a chemotherapeutic agent used in treating various cancers, particularly gastric, pancreatic, bladder, and breast cancer. It is a DNA synthesis inhibitor, effectively targeting and destroying rapidly dividing cancer cells.
Uses of Mitowel
Treatment of advanced gastric and pancreatic cancers.
Used as intravesical therapy for bladder cancer.
Part of combination therapy for solid tumors.
Benefits of Mitowel
Effective against multiple types of cancer.
Can be administered intravenously or intravesically.
Inhibits cancer cell proliferation at the DNA level.
Enhances survival rates when used in combination therapy.
Mechanism of Action of Mitowel
Acts as an alkylating agent, crosslinking DNA strands.
Prevents DNA replication and induces apoptosis.
Targets rapidly dividing cancer cells, reducing tumor progression.
Mitowel – Advancing Cancer Treatment with Precision!